ASX - Delayed Quote AUD
AnteoTech Limited (ADO.AX)
0.0070
-0.0010
(-12.50%)
At close: 4:10:07 PM GMT+10
Insider Purchases Last 6 Months
Shares | Transactions | |
---|---|---|
Purchases | 0 | 0 |
Sales | -- | 0 |
Net Shares Purchased (Sold) | 0 | 0 |
Total Insider Shares Held | 432.98M | -- |
% Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
Shares | |
---|---|
Net Shares Purchased (Sold) | -- |
% Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
Insider | Transaction | Type | Value | Date |
---|---|---|---|---|
Crouch (Ewen Graham Wolseley) Former | -- | Direct | -- | Apr 14, 2025 |
Crouch (Ewen Graham Wolseley) Independent Non-Executive Chairman | Other at price 0.01 per share. | Direct | 5,635 | Dec 16, 2024 |
Cumming (Geoffrey James Ph.D.) Independent Non-Executive Director | Other at price 0.01 per share. | Direct | 12,700 | Dec 16, 2024 |
McLoughlin (Glenda A.) Independent Non-Executive Director | Other at price 0.01 per share. | Direct | 1,508 | Dec 16, 2024 |
Radford (David John) Chief Executive Officer | Other at price 0.01 per share. | Direct | 6,576 | Dec 16, 2024 |
Woodthorpe (Katherine) Director (Non-Executive) | Other at price 0.01 per share. | Direct | 1,016 | Dec 16, 2024 |
Radford (David John) Chief Executive Officer | Purchase at price 0.02 per share. | Direct | 11,385 | Oct 2, 2024 |
Radford (David John) Chief Executive Officer | -- | Direct | -- | Sep 13, 2024 |
Woodthorpe (Katherine) Director (Non-Executive) | -- | Indirect | -- | Jun 30, 2024 |
Crouch (Ewen Graham Wolseley) Independent Non-Executive Chairman | Other at price 0.02 per share. | Direct | 33,200 | May 31, 2024 |
Cumming (Geoffrey James Ph.D.) Independent Non-Executive Director | Other at price 0.02 per share. | Direct | 19,920 | May 31, 2024 |
Woodthorpe (Katherine) Director (Non-Executive) | Other at price 0.02 per share. | Direct | 13,280 | May 31, 2024 |
Crouch (Ewen Graham Wolseley) Independent Non-Executive Chairman | Other at price 0.02 per share. | Direct | 19,218 | Sep 11, 2023 |
Parker (Christopher) Former | -- | Direct | -- | Jun 30, 2023 |
Crouch (Ewen Graham Wolseley) Independent Non-Executive Chairman | Other at price 0.02 per share. | Direct | 15,075 | Apr 5, 2023 |
Cumming (Geoffrey James Ph.D.) Independent Non-Executive Director | Exercise at price 0.02 per share. | Direct | 36,997 | Apr 5, 2023 |
Radford (David John) Chief Executive Officer | Exercise at price 0.02 per share. | Direct | 13,399 | Apr 5, 2023 |
Cumming (Geoffrey James Ph.D.) Independent Non-Executive Director | Sale at price 0.02 per share. | Direct | 44,176 | Mar 29, 2023 |
Cumming (Geoffrey James Ph.D.) Independent Non-Executive Director | Sale at price 0.04 per share. | Direct | 40,900 | Dec 16, 2022 |
Parker (Christopher) Director (Executive) | Exercise at price 0.02 per share. | Direct | 10,000 | Dec 16, 2022 |
Crouch (Ewen Graham Wolseley) Independent Non-Executive Chairman | Purchase at price 0.03 per share. | Direct | 16,700 | Nov 23, 2022 |
Cornish (Duncan Patrick) Former | -- | Direct | -- | Jun 30, 2022 |
Cumming (Geoffrey James Ph.D.) Director (Non-Executive) | Sale at price 0.05 per share. | Direct | 73,050 | Jun 14, 2022 |
Crouch (Ewen Graham Wolseley) Non Executive Chairman | Purchase at price 0.08 per share. | Direct | 19,225 | May 9, 2022 |
Cumming (Geoffrey James Ph.D.) Director (Non-Executive) | Sale at price 0.08 per share. | Direct | 156,000 | May 3, 2022 |
Cumming (Geoffrey James Ph.D.) Director (Non-Executive) | Sale at price 0.16 per share. | Direct | 78,200 | Dec 23, 2021 |
McLoughlin (Glenda A.) Director (Non-Executive) | -- | Direct | -- | Sep 17, 2021 |
Thomson (Derek) Chief Executive Officer | -- | Direct | -- | Aug 24, 2021 |
Cumming (Geoffrey James Ph.D.) Director (Non-Executive) | Sale at price 0.17 per share. | Direct | 82,750 | Aug 2, 2021 |
Cornish (Duncan Patrick) Company Secretary | -- | Direct | -- | Jun 30, 2021 |
Cumming (Geoffrey James Ph.D.) Director (Non-Executive) | -- | Indirect | -- | Jun 30, 2021 |
Cumming (Geoffrey James Ph.D.) Director (Non-Executive) | Other at price 0.20 per share. | Direct | 3,499 | May 25, 2021 |
Cumming (Geoffrey James Ph.D.) Director (Non-Executive) | Other at price 0.20 per share. | Direct | 3,499 | May 25, 2021 |
Parker (Christopher) Director (Executive) | Other at price 0.20 per share. | Direct | 3,499 | May 25, 2021 |
Parker (Christopher) Director (Executive) | Other at price 0.20 per share. | Direct | 3,499 | May 25, 2021 |
Sanderson (Matthew) Former | -- | Direct | -- | Apr 22, 2021 |
Cumming (Geoffrey James Ph.D.) Director (Non-Executive) | Exercise at price 0.01 per share. | Direct | 21,729 | Dec 6, 2020 |
Cumming (Geoffrey James Ph.D.) Director (Non-Executive) | Sale at price 0.07 per share. | Direct | 95,129 | Nov 27, 2020 |
Sanderson (Matthew) Director (Non-Executive) | Exercise at price 0.01 per share. | Direct | 38,112 | Nov 23, 2020 |
Cornish (Duncan Patrick) Company Secretary | -- | Direct | -- | Jun 30, 2020 |
Cumming (Geoffrey James Ph.D.) Director (Non-Executive) | Other at price 0.01 per share. | Direct | 33,868 | Mar 31, 2020 |
Parker (Christopher) Director (Executive) | Other at price 0.01 per share. | Direct | 9,200 | Mar 31, 2020 |
Sanderson (Matthew) Director (Non-Executive) | Other at price 0.01 per share. | Direct | 8,597 | Mar 31, 2020 |
Maeji (Nobuyoshi Joe Ph.D.) Divisional Officer | -- | Direct | -- | Jun 30, 2019 |
Cumming (Geoffrey James Ph.D.) Director (Non-Executive) | Acquisition at price 0.01 per share. | Direct | 22,316 | Jun 6, 2019 |
Sanderson (Matthew) Director (Non-Executive) | Acquisition at price 0.01 per share. | Direct | 39,952 | Jun 6, 2019 |
Vangenechten (Jef) Former | -- | Direct | -- | Jun 30, 2018 |
Sickman (Rolf) Former | -- | Direct | -- | Mar 31, 2018 |
Studley (Alan Thomas) Former | -- | Direct | -- | Nov 16, 2017 |
Hurrell John G R Chairman of the Board | Purchase at price 0.01 per share. | Direct | 6,900 | Nov 9, 2017 |
Related Tickers
AAGH America Great Health
0.0050
0.00%
OMER Omeros Corporation
6.97
-2.52%
SXTP 60 Degrees Pharmaceuticals, Inc.
3.0100
+12.73%
CMND Clearmind Medicine Inc.
0.9764
-2.36%
SLS SELLAS Life Sciences Group, Inc.
1.3100
+1.55%
EVGN Evogene Ltd.
1.0900
-2.68%
PHIO Phio Pharmaceuticals Corp.
2.0400
-18.73%
MURA Mural Oncology plc
2.7700
+1.84%
CHRO Channel Therapeutics Corporation
1.3700
-11.61%
EDIT Editas Medicine, Inc.
1.5600
0.00%